| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 26549-61-1 | VirgiNIAMycin S1,5-[(2S)-4-hydroxy-2-piperidinecarboxylic acid]- (9CI); StaphylomycinS, 5-(4-hydroxy-L-pipecolic acid)- (8CI); VirgiNIAMycin S1, 5-(4-hydroxy-L-2-piperidinecarboxylicacid)-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Dihydrostaphylomycin S; DihydrovirgiNIAMycin S1; VirgiNIAMycin S1, dihydro- |  | C43H51N7O10 | 詳情 | 供應(yīng)商 | |
| 23152-29-6 | VirgiNIAMycin S1; StaphylomycinS (6CI,7CI,8CI); 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Antibiotic 1754Z3B; Factor S; Factor S (antibiotic); Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-,r-lactone; N-[(3-Hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenylglyciner-lactone; Staphylomycin S1 |  | C43H49N7O10 | 詳情 | 供應(yīng)商 | |
| 33477-37-1 | VirgiNIAMycin S4 (9CI); VirgiNIAMycinS1, 2-D-alanine-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-alanyl-L-prolyl-N-methyl-L-phenylalanyl-4-oxo-L-2-piperidinecarbonyl-L-2-phenyl-,r-lactone; Staphylomycin S4 |  | C42H49N7O10 | 詳情 | 供應(yīng)商 | |
| 14014-70-1 | Vernamycin C (8CI,9CI); Doricin(7CI); VirgiNIAMycin S1, 4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-5-L-asparticacid-; Pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine, cyclic peptidederiv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-2-aminobutanoyl-L-prolyl-4-(dimethylamino)-N-methyl-L-phenylalanyl-L-a-aspartyl-L-2-phenyl-, r-lactone |  | C43H52N8O11 | 詳情 | 供應(yīng)商 | |
| 29139-17-1 | Vernamycin Bd (7CI,9CI); VirgiNIAMycinS1, 2-D-alanine-4-[N-methyl-4-(methylamino)-L-phenylalanine]-; 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Glycine,N-[(3-hydroxy-2-pyridinyl)carbonyl]-L-threonyl-D-alanyl-L-prolyl-N-methyl-4-(methylamino)-L-phenylalanyl-4-oxo-L-pipecoloyl-L-2-phenyl-,r-lactone |  | C43H52N8O10 | 詳情 | 供應(yīng)商 | |
| 33477-39-3 | VirgiNIAMycin S1,5-[(2S)-5-hydroxy-4-oxo-2-piperidinecarboxylic acid]-; VirgiNIAMycinS1, 5-(5-hydroxy-4-oxo-L-2-piperidinecarboxylic acid)-; VirgiNIAMycin S3(8CI,9CI); 12H-Pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Staphylomycin S3 |  | C43H49N7O11 | 詳情 | 供應(yīng)商 | |
| 21411-53-0 | VIRGINIAMYCIN M1; MIKAMYCIN A; STAPHYLOMYCIN; VIRGINIAMYCINE; VIRGINIAMYCIN M1; C11299; MikamycinA, Staphylomycin; Antibiotic PA-114A1; Pristinamycin IIA |  | C28H35N3O7 | 詳情 | 供應(yīng)商 |